Evaluation of bronchodilator responses in patients with "irreversible" emphysema

European Respiratory Journal

Volumn 18, Issue 6, 2001, Pages 914-920

  O'Donnell, D E ^a   Forkert, L ^a   Webb, K A ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Bronchodilators; Chronic obstructive pulmonary disease; Emphysema; Inspiratory capacity; Lung Hyperinflation; Reversibility criteria

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE; SALBUTAMOL; THEOPHYLLINE;

ADULT; AGED; ARTICLE; BODY PLETHYSMOGRAPHY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG RESPONSE; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL RESIDUAL CAPACITY; HUMAN; INSPIRATORY CAPACITY; LUNG EMPHYSEMA; LUNG INFLATION; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESIDUAL VOLUME; SPIROMETRY; TOTAL LUNG CAPACITY; VITAL CAPACITY;

AGED; ALBUTEROL; BRONCHODILATOR AGENTS; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL RESIDUAL CAPACITY; HUMANS; INSPIRATORY CAPACITY; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; TOTAL LUNG CAPACITY; VITAL CAPACITY;

EID: 0035691634     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.01.00216501     Document Type: Article

References (25)

1. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease
2. Measurement of symptoms, lung hyperinflation and endurance during exercise in chronic obstructive pulmonary disease
3. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease
4. Assessment of bronchodilator efficacy in symptomatic COPD: Is spirometry useful?
5. Lung mechanics in disease
6. Expiratory flow limitation
7. Predictors of maximum exercise tolerance in patients with COPD
8. Mechanisms by which COPD affects exercise tolerance
9. Exertional breathlessness in patients with chronic airflow limitation: The role of lung hyperinflation
10. Exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest
11. Dynamic hyperinflation and exercise intolerance in COPD
12. Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients
13. Salmeterol reduces dyspnea and improves lung function in patients with COPD
14. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global initiative for chronic obstructive lung disease (GOLD) workshop summary
15. ERS -consensus statement: Optimal assessment and management of chronic obstructive pulmonary disease (COPD)
16. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma
17. Standardization of spirometry-1994 update
18. Effect of panting frequency on the plethysmographic determination of thoracic gas volume in chronic obstructive pulmonary disease
19. Fifteen year interval spirometric evaluation of the Oregon predictive equations
20. Lung volumes in healthy nonsmoking adults
21. Clinical usefulness of the single-breath pulmonary diffusing capacity test
22. Response of lung volumes to inhaled albuterol in a large population of patients with severe hyperinflation
23. Lung hyperinflation and flow limitation in chronic airway obstruction
24. Effects of ipratropium bromide and fenoterol aerosols in pulmonary emphysema
25. Determination of static pulmonary volumes after bronchodilator therapy